Table 1 Details of the articles that mention asthma
Citation | Title | DOI | Mention to respiratory disease except from asthma | Number (%) respiratory disease except from asthma | Mention to asthma | Number (%) asthma patients | Number of COVID-19 patients |
|---|---|---|---|---|---|---|---|
Alkundi A, et al.. | Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study | 10.1016/j.diabres.2020.108263 | Yes | COPD: 7 (7.3%) | Yes | 6 (2.6%) | 232 |
Alsofayan YM, et al. | Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study | 10.1016/j.jiph.2020.05.026 | Yes | Chronic lung disease: 57 (5.2%) | Yes | 54 (4.9%) | 1519 |
Aretz M, et al. | Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State | 10.1001/jama.2020.4326 | Yes | COPD: 7 (33.3%) | Yes | 2 (9.1%) | 21 |
Asghar MS, et al. | Clinical Profiles, Characteristics, and Outcomes of the First 100 Admitted COVID-19 Patients in Pakistan: A Single-Center Retrospective Study in a Tertiary Care Hospital of Karachi | 10.7759/cureus.8712 | Yes | COPD: 3 (3%) | Yes | 2 (2%) | 100 |
Benger M, et al. | Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series | 10.1016/j.bbi.2020.06.005 | No | – | Yes | 1 (20%) | 5 |
Bhatraju PK, et al. | Covid-19 in Critically Ill Patients in the Seattle Region — Case Series | 10.1056/NEJMoa2004500 | Yes | COPD: 1 (4%) | Yes | 3 (12.5%) | 24 |
Chao JY, et al. | Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City | 10.1016/j.jpeds.2020.05.006 | No | – | Yes | 11 (24.4%) | 46 |
Cheng FY, et al. | Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients | 10.3390/jcm9061668 | Yes | COPD: 219 (8.42%) | Yes | 219 (8.42%) | 2599 |
Cheung ZB and Forsh DA | Early outcomes after hip fracture surgery in COVID-19 patients in New York City | 10.1016/j.jor.2020.06.003 | Yes | COPD: 1 (10%) | Yes | 2 (20%) | 10 |
Chhiba KD, et al. | Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 | 10.1016/j.jaci.2020.06.010 | Yes | COPD: 111 (7.27%) | Yes | 220 (14.2%) | 1542 |
D'Silva KM, et al. | Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot' | 10.1136/annrheumdis-2020-217888 | Yes | COPD: 9 (5.7%) | Yes | 31 (19.8%) | 156 |
Du H, et al. | Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status | 10.1111/all.14452 | No | – | Yes | 1 (2.3%) | 43 |
Duanmu Y, et al. | Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications | 10.1111/acem.14003 | Yes | COPD: 1 (10%) | Yes | 10 (10%) | 100 |
Fan J, et al. | The epidemiology of reverse transmission of COVID-19 in Gansu Province, China | 10.1016/j.tmaid.2020.101741 | Yes | COPD: N/A | Yes | N/A | 37 |
Fernandéz R, et al. | COVID-19 in Solid Organ Transplant Recipients: A Single-Center Case Series from Spain | 10.1111/ajt.15929 | No | – | Yes | 1 (5.55%) | 18 |
Gayam V, et al. | Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA | 10.1002/jmv.26026 | No | – | Yes | 2 (33.3%) | 6 |
Gold JAW, et al. | Characteristics and Clinical Outcomes of Adult Patients Hospitalized With COVID-19—Georgia, March 2020 | 10.15585/mmwr.mm6918e1 | Yes | COPD: 16 (5.2%) | Yes | 32 (10.5%) | 305 |
Goyal P, et al. | Clinical Characteristics of Covid-19 in New York City | 10.1056/NEJMc2010419 | Yes | COPD: 20 (5.1%) | Yes | 49 (12.5%) | 393 |
Huang D, et al. | A novel risk score to predict diagnosis with coronavirus disease 2019 (COVID-19) in suspected patients: A retrospective, multicenter, and observational study | 10.1002/jmv.26143 | Yes | COPD: 9 (2.7%) | Yes | 5 (1.5%) | 336 |
Jehi L, et al. | Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results From 11,672 Patients | 10.1016/j.chest.2020.05.580 | Yes | COPD/emphysema: 14 (1.26%) | Yes | 163 (14.7%) | 1108 |
Kaushik S, et al. | Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City | 10.1016/j.jpeds.2020.06.045 | No | – | Yes | 5 (15%) | 33 |
Knight M, et al. | Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population-based cohort study | 10.1136/bmj.m2107 | No | – | Yes | 31 (7%) | 427 |
Korkmaz MF, et al. | The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study | 10.3346/jkms.2020.35.e236 | No | – | Yes | 1 (1.23%) | 81 |
Lechien JR, et al.. 2020 | Clinical and Epidemiological Characteristics of 1,420 European Patients With Mild-To-Moderate Coronavirus Disease 2019 | 10.1111/joim.13089 | Yes | Respiratory insufficiency: 10 (0.7%) | Yes | 93 (6.5%) | 1420 |
Li X, et al.. 2020 | Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan | 10.1016/j.jaci.2020.04.006 | Yes | COPD: 17 (3.1%) | Yes | 5 (0.9%) | 548 |
Liabeuf S, et al. | Association between renin-angiotensin system inhibitors and COVID-19 complications | 10.1093/ehjcvp/pvaa062 | Yes | COPD: 26 (10%) | Yes | 14 (5%) | 268 |
Liu BM, et al. | Epidemiological characteristics of COVID-19 patients in convalescence period | 10.1017/S0950268820001181 | Yes | Pulmonary tuberculosis: 4 (5.9%) | Yes | 1 (1.5%) | 68 |
Liu D, et al. | The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study | 10.1186/s12931-020.01385-1 | No | – | Yes | 4 (2.8%) | 149 |
Lokken EM, et al. | Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State | 10.1016/j.ajog.2020.05.031 | No | – | Yes | 4 (8.7%) | 46 |
Magagnoli et al. | Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19 | 10.1016/j.medj.2020.06.001 | Yes | COPD: 175 (21.68%) | Yes | 40 (4.95%) | 807 |
Mestre-Goméz B, et al. | Incidence of pulmonary embolism in non‑critically ill COVID‑19 patients. Predicting factors for a challenging diagnosis | 10.1007/s11239-020-02190-9 | Yes | Chronic obstrutive lung disease: 13 (14.28%) | Yes | 7 (7.69%) | 91 |
Mikami T, et al. | Risk Factors for Mortality in Patients with COVID-19 in New York City | 10.1007/s11606-020-05983-z | Yes | COPD: 176 (2.7%) | Yes | 271 (4.2%) | 6493 |
Mitra AR, et al. | Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series | 10.1503/cmaj.200794 | Yes | COPD: 8 (6.8%) | Yes | 14 (12%) | 117 |
Oualha M, et al. | Severe and fatal forms of COVID-19 in children | 10.1016/j.arcped.2020.05.010 | Yes | COPD: 1 (3.7%) e Chronic lung disease: 2 (7.4%) | Yes | 1 (3.7%) | 27 |
Pare JR, et al. | Point-of-care Lung Ultrasound Is More Sensitive than Chest Radiograph for Evaluation of COVID-19 | 10.5811/westjem.2020.5.47743 | Yes | COPD: 1 (3.7%) | Yes | 4 (14.8%) | 27 |
Peyrony O, et al. | Accuracy of Emergency Department Clinical Findings for Diagnosis of Coronavirus Disease 2019 | 10.1016/j.annemergmed.2020.05.022 | Yes | COPD: 24 (6.2%) | Yes | 22 (5.7%) | 391 |
Phipps MM, et al. | Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort | 10.1002/hep.31404 | Yes | COPD: 185 (8.1%) | Yes | 308 (14) | 2273 |
Pongpirul WA, et al. | Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand | 10.3201/eid2607.200598 | Yes | COPD: 0 | Yes | 0 | 11 |
Price-Haywood EG, et al. | Hospitalization and Mortality among Black Patients and White Patients with Covid-19 | 10.1056/NEJMsa2011686 | Yes | COPD: 79 (2.25%) | Yes | 147 (4%) | 3481 |
Richardson S, et al. | Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area | 10.1001/jama.2020.6775 | Yes | COPD: 287 (5.4%) | Yes | 479 (9%) | 5700 |
San-Juan R, et al. | Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain | 10.1016/j.eclinm.2020.100407 | No | – | Yes | 4 (12.5%) | 32 |
Satici C, et al. | Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19 | 10.1016/j.ijid.2020.06.038 | Yes | COPD: 28 (4.1%) | Yes | 43 (6.3%) | 681 |
Sentilhes L, et al. | Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth | 10.1016/j.ajog.2020.06.022 | No | – | Yes | 5 (9.3%) | 54 |
Shahriarirad R, et al. | Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran | 10.1186/s12879-020-05128-x | Yes | COPD: 9 (8%) | Yes | 7 (6.2%) | 113 |
Smith SM, et al. | Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19 | 10.1002/jmv.26227 | Yes | COPD: 12 (6.5%) | Yes | 18 (9.8%) | 184 |
Solís and Carreňo | COVID-19 Fatality and Comorbidity Risk Factors among Diagnosed Patients in Mexico | 10.1101/2020.04.21.20074591 | Yes | COPD: 202 (2.7%) | Yes | 270 (3.6%) | 7497 |
Sultan I, et al. | The Role of Extracorporeal Life Support for Patients With COVID-19: Preliminary Results from a Statewide Experience | 10.1111/jocs.14583 | No | – | Yes | N/A | 10 |
Wang X, et al. | Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China | 10.1183/13993003.00544-2020 | No | – | Yes | 2 (5.7%) | 35 |
Zhang C, et al. | Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series | 10.1371/journal.pmed.1003130 | No | – | Yes | 1 (3%) | 34 |
Zhang JJ, et al. | Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China | 10.1111/all.14238 | Yes | COPD: 2 (1.4%) | Yes | 0 | 140 |
Zhao M, et al. | Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages | 10.18632/aging.103298 | Yes | COPD: 23 (2.3%) | Yes | 12 (1.2%) | 1000 |
Zhou X, et al. | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) Patients with Hypertension on Renin-Angiotensin System Inhibitors | 10.1080/10641963.2020.1764018 | Yes | COPD:3 (2.7%) | Yes | 1 (0.9%) | 110 |